NorthWest Biotherapeutics Inc (NWBO)

[doingmybest]

The timing of Q3 2019 is interesting. The initial 199m2 is not a significant size but the initial licensing is the most difficult for a new enterprise. The expansion capability of addl 7500m2 is significant and they will want to begin the next phase as soon as possible. The additions will have been planned in phases and in a way that interruption to current operations is quite minimal. They are doing the right things and just need financing to keep moving in lockstep with expected approvals.